AKT1/2 Antikörper (N-Term)
Kurzübersicht für AKT1/2 Antikörper (N-Term) (ABIN1820858)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Human AKT1 and AKT2. Species Crossreactivity: Mouse and rat.
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Synthetic peptide corresponding to human AKT1/2 at N-terminal.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: IHC (2 μg/mL), WB (1 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 5 mg BSA, 0.9 mg sodium chloride, 0.2 mg disodium hydrogen phosphate, 0.05 mg Thimerosal, 0.05 mg sodium azide
-
Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
-
-
- AKT1/2 (V-Akt Murine Thymoma Viral Oncogene Homolog 1/2 (AKT1/2))
-
Andere Bezeichnung
- AKT1 + AKT2
-
Hintergrund
-
Name/Gene ID: AKT1/AKT2
Synonyms: AKT1/AKT2
This antibody detects: AKT1 + AKT2
Target
-